img

Global Covid-19 Small Molecule Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Covid-19 Small Molecule Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Covid-19 Small Molecule Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Covid-19 Small Molecule Drugs market research.
Key companies engaged in the Covid-19 Small Molecule Drugs industry include Shanghai Junshi biosciences, Ascletis Pharma, Merck and Co (MSD), Pfizer and Shionogi, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Covid-19 Small Molecule Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Covid-19 Small Molecule Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Covid-19 Small Molecule Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Shanghai Junshi biosciences
Ascletis Pharma
Merck and Co (MSD)
Pfizer
Shionogi
Segment by Type
RdRp
3CLpro

Segment by Application


Hospital
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Covid-19 Small Molecule Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Small Molecule Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 RdRp
1.2.3 3CLpro
1.3 Market by Application
1.3.1 Global Covid-19 Small Molecule Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Small Molecule Drugs Market Perspective (2018-2034)
2.2 Covid-19 Small Molecule Drugs Growth Trends by Region
2.2.1 Global Covid-19 Small Molecule Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Covid-19 Small Molecule Drugs Historic Market Size by Region (2018-2023)
2.2.3 Covid-19 Small Molecule Drugs Forecasted Market Size by Region (2024-2034)
2.3 Covid-19 Small Molecule Drugs Market Dynamics
2.3.1 Covid-19 Small Molecule Drugs Industry Trends
2.3.2 Covid-19 Small Molecule Drugs Market Drivers
2.3.3 Covid-19 Small Molecule Drugs Market Challenges
2.3.4 Covid-19 Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Small Molecule Drugs Players by Revenue
3.1.1 Global Top Covid-19 Small Molecule Drugs Players by Revenue (2018-2023)
3.1.2 Global Covid-19 Small Molecule Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Covid-19 Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Small Molecule Drugs Revenue
3.4 Global Covid-19 Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Covid-19 Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Small Molecule Drugs Revenue in 2024
3.5 Covid-19 Small Molecule Drugs Key Players Head office and Area Served
3.6 Key Players Covid-19 Small Molecule Drugs Product Solution and Service
3.7 Date of Enter into Covid-19 Small Molecule Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Small Molecule Drugs Breakdown Data by Type
4.1 Global Covid-19 Small Molecule Drugs Historic Market Size by Type (2018-2023)
4.2 Global Covid-19 Small Molecule Drugs Forecasted Market Size by Type (2024-2034)
5 Covid-19 Small Molecule Drugs Breakdown Data by Application
5.1 Global Covid-19 Small Molecule Drugs Historic Market Size by Application (2018-2023)
5.2 Global Covid-19 Small Molecule Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Covid-19 Small Molecule Drugs Market Size (2018-2034)
6.2 North America Covid-19 Small Molecule Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Covid-19 Small Molecule Drugs Market Size by Country (2018-2023)
6.4 North America Covid-19 Small Molecule Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Small Molecule Drugs Market Size (2018-2034)
7.2 Europe Covid-19 Small Molecule Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Covid-19 Small Molecule Drugs Market Size by Country (2018-2023)
7.4 Europe Covid-19 Small Molecule Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Small Molecule Drugs Market Size (2018-2034)
8.2 Asia-Pacific Covid-19 Small Molecule Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Small Molecule Drugs Market Size (2018-2034)
9.2 Latin America Covid-19 Small Molecule Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Covid-19 Small Molecule Drugs Market Size by Country (2018-2023)
9.4 Latin America Covid-19 Small Molecule Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Small Molecule Drugs Market Size (2018-2034)
10.2 Middle East & Africa Covid-19 Small Molecule Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Junshi biosciences
11.1.1 Shanghai Junshi biosciences Company Detail
11.1.2 Shanghai Junshi biosciences Business Overview
11.1.3 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Introduction
11.1.4 Shanghai Junshi biosciences Revenue in Covid-19 Small Molecule Drugs Business (2018-2023)
11.1.5 Shanghai Junshi biosciences Recent Development
11.2 Ascletis Pharma
11.2.1 Ascletis Pharma Company Detail
11.2.2 Ascletis Pharma Business Overview
11.2.3 Ascletis Pharma Covid-19 Small Molecule Drugs Introduction
11.2.4 Ascletis Pharma Revenue in Covid-19 Small Molecule Drugs Business (2018-2023)
11.2.5 Ascletis Pharma Recent Development
11.3 Merck and Co (MSD)
11.3.1 Merck and Co (MSD) Company Detail
11.3.2 Merck and Co (MSD) Business Overview
11.3.3 Merck and Co (MSD) Covid-19 Small Molecule Drugs Introduction
11.3.4 Merck and Co (MSD) Revenue in Covid-19 Small Molecule Drugs Business (2018-2023)
11.3.5 Merck and Co (MSD) Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Covid-19 Small Molecule Drugs Introduction
11.4.4 Pfizer Revenue in Covid-19 Small Molecule Drugs Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Shionogi
11.5.1 Shionogi Company Detail
11.5.2 Shionogi Business Overview
11.5.3 Shionogi Covid-19 Small Molecule Drugs Introduction
11.5.4 Shionogi Revenue in Covid-19 Small Molecule Drugs Business (2018-2023)
11.5.5 Shionogi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Covid-19 Small Molecule Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of RdRp
Table 3. Key Players of 3CLpro
Table 4. Global Covid-19 Small Molecule Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Covid-19 Small Molecule Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Covid-19 Small Molecule Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Covid-19 Small Molecule Drugs Market Share by Region (2018-2023)
Table 8. Global Covid-19 Small Molecule Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Covid-19 Small Molecule Drugs Market Share by Region (2024-2034)
Table 10. Covid-19 Small Molecule Drugs Market Trends
Table 11. Covid-19 Small Molecule Drugs Market Drivers
Table 12. Covid-19 Small Molecule Drugs Market Challenges
Table 13. Covid-19 Small Molecule Drugs Market Restraints
Table 14. Global Covid-19 Small Molecule Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Covid-19 Small Molecule Drugs Market Share by Players (2018-2023)
Table 16. Global Top Covid-19 Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Small Molecule Drugs as of 2024)
Table 17. Ranking of Global Top Covid-19 Small Molecule Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Covid-19 Small Molecule Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Covid-19 Small Molecule Drugs Product Solution and Service
Table 21. Date of Enter into Covid-19 Small Molecule Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Covid-19 Small Molecule Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Covid-19 Small Molecule Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Covid-19 Small Molecule Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Covid-19 Small Molecule Drugs Revenue Market Share by Type (2024-2034)
Table 27. Global Covid-19 Small Molecule Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Covid-19 Small Molecule Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Covid-19 Small Molecule Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Covid-19 Small Molecule Drugs Revenue Market Share by Application (2024-2034)
Table 31. North America Covid-19 Small Molecule Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Covid-19 Small Molecule Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Covid-19 Small Molecule Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Covid-19 Small Molecule Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Covid-19 Small Molecule Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Covid-19 Small Molecule Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Covid-19 Small Molecule Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Covid-19 Small Molecule Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Covid-19 Small Molecule Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Covid-19 Small Molecule Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Covid-19 Small Molecule Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 46. Shanghai Junshi biosciences Company Detail
Table 47. Shanghai Junshi biosciences Business Overview
Table 48. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Product
Table 49. Shanghai Junshi biosciences Revenue in Covid-19 Small Molecule Drugs Business (2018-2023) & (US$ Million)
Table 50. Shanghai Junshi biosciences Recent Development
Table 51. Ascletis Pharma Company Detail
Table 52. Ascletis Pharma Business Overview
Table 53. Ascletis Pharma Covid-19 Small Molecule Drugs Product
Table 54. Ascletis Pharma Revenue in Covid-19 Small Molecule Drugs Business (2018-2023) & (US$ Million)
Table 55. Ascletis Pharma Recent Development
Table 56. Merck and Co (MSD) Company Detail
Table 57. Merck and Co (MSD) Business Overview
Table 58. Merck and Co (MSD) Covid-19 Small Molecule Drugs Product
Table 59. Merck and Co (MSD) Revenue in Covid-19 Small Molecule Drugs Business (2018-2023) & (US$ Million)
Table 60. Merck and Co (MSD) Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Covid-19 Small Molecule Drugs Product
Table 64. Pfizer Revenue in Covid-19 Small Molecule Drugs Business (2018-2023) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Shionogi Company Detail
Table 67. Shionogi Business Overview
Table 68. Shionogi Covid-19 Small Molecule Drugs Product
Table 69. Shionogi Revenue in Covid-19 Small Molecule Drugs Business (2018-2023) & (US$ Million)
Table 70. Shionogi Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Small Molecule Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Covid-19 Small Molecule Drugs Market Share by Type: 2024 VS 2034
Figure 3. RdRp Features
Figure 4. 3CLpro Features
Figure 5. Global Covid-19 Small Molecule Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Covid-19 Small Molecule Drugs Market Share by Application: 2024 VS 2034
Figure 7. Hospital Case Studies
Figure 8. Scientific Research Case Studies
Figure 9. Covid-19 Small Molecule Drugs Report Years Considered
Figure 10. Global Covid-19 Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Covid-19 Small Molecule Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Covid-19 Small Molecule Drugs Market Share by Region: 2024 VS 2034
Figure 13. Global Covid-19 Small Molecule Drugs Market Share by Players in 2024
Figure 14. Global Top Covid-19 Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Small Molecule Drugs as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Covid-19 Small Molecule Drugs Revenue in 2024
Figure 16. North America Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Covid-19 Small Molecule Drugs Market Share by Country (2018-2034)
Figure 18. United States Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. Canada Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Europe Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Covid-19 Small Molecule Drugs Market Share by Country (2018-2034)
Figure 22. Germany Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. France Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. U.K. Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Italy Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Russia Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Nordic Countries Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Asia-Pacific Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Covid-19 Small Molecule Drugs Market Share by Region (2018-2034)
Figure 30. China Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Japan Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. South Korea Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Southeast Asia Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. India Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Australia Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Latin America Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Covid-19 Small Molecule Drugs Market Share by Country (2018-2034)
Figure 38. Mexico Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Brazil Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Middle East & Africa Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Covid-19 Small Molecule Drugs Market Share by Country (2018-2034)
Figure 42. Turkey Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Saudi Arabia Covid-19 Small Molecule Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Shanghai Junshi biosciences Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2018-2023)
Figure 45. Ascletis Pharma Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2018-2023)
Figure 46. Merck and Co (MSD) Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2018-2023)
Figure 48. Shionogi Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed